Explore whether existing approved treatment approaches for cutaneous leishmaniasis are more effective when used in combination
current phase of drug development
updated 29 Feb 2020
When administrated alone, the safety and efficacy profiles of current cutaneous leishmaniasis treatments (antimonials, miltefosine, and thermotherapy) are well established. Using a combination of therapeutic approaches may improve efficacy rates, reduce treatment duration, and improve the rate of adverse events. The Phase II study aims to assess whether a combination of thermotherapy with a shorter course of oral miltefosine achieves better results than thermotherapy alone.
Get our latest news, personal stories, research articles, and job opportunities.